In contrast to other breast cancer subtypes (triple-negative and HER2-positive) where TILs are associated with decreased mutation number, believed to be due to tumor immunoediting of clones with high mutation burden, in ER-positive cancers, total mutation number is significantly associated with the presence of TILs [43]. The gene discussed is ERBB2; the disease is breast carcinoma.